Loading…

Hologic has entered a definitive agreement to acquire Finnish-French molecular diagnostic test developer Mobidiag for an enterprise value of approximately $795 million, including $714 million in cash for equity and $81 million in net debt.
“Hologic has entered a definitive agreement to acquire Finnish-French molecular diagnostic test developer Mobidiag for an enterprise value of approximately $795m.”medicaldevice-network.com
Summarized from public sources; check the original articles before acting on it.